| Year |
Citation |
Score |
| 2012 |
Lee DL, Strathmann FG, Gelein R, Walton J, Mayer-Pröschel M. Iron deficiency disrupts axon maturation of the developing auditory nerve. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 5010-5. PMID 22492056 DOI: 10.1523/Jneurosci.0526-12.2012 |
0.658 |
|
| 2011 |
Mihaila C, Schramm J, Strathmann FG, Lee DL, Gelein RM, Luebke AE, Mayer-Pröschel M. Identifying a window of vulnerability during fetal development in a maternal iron restriction model. Plos One. 6: e17483. PMID 21423661 DOI: 10.1371/Journal.Pone.0017483 |
0.362 |
|
| 2011 |
Latchney SE, Lioy DT, Henry EC, Gasiewicz TA, Strathmann FG, Mayer-Pröschel M, Opanashuk LA. Neural precursor cell proliferation is disrupted through activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Stem Cells and Development. 20: 313-26. PMID 20486776 DOI: 10.1089/Scd.2009.0529 |
0.346 |
|
| 2007 |
Strathmann FG, Wang X, Mayer-Pröschel M. Identification of two novel glial-restricted cell populations in the embryonic telencephalon arising from unique origins. Bmc Developmental Biology. 7: 33. PMID 17439658 DOI: 10.1186/1471-213X-7-33 |
0.335 |
|
| 2006 |
Mock DJ, Strathmann F, Blumberg BM, Mayer-Proschel M. Infection of murine oligodendroglial precursor cells with Human Herpesvirus 6 (HHV-6)--establishment of a murine in vitro model. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 37: S17-23. PMID 17276361 DOI: 10.1016/S1386-6532(06)70006-3 |
0.672 |
|
| 2006 |
Mock DJ, Chugh P, Kim B, Pröschel C, Dietrich J, Strathmann F, Blumberg BM, Mayer-Pröschel M. Characterization of specific HHV-6 and cell cycle genes implicated in virus-mediated G1/S cell-cycle arrest of glial precursors Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-S65 |
0.668 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Velez-Quinones MA, Xu H, Vo N, Gaitens JM, McDiarmid MA, Lewin-Smith MR, Strathmann FG. Determination of Thirteen Trace and Toxic Elements in Urine Using Inductively Coupled Mass Spectrometry. Current Protocols in Toxicology. e58. PMID 30238639 DOI: 10.1002/cptx.58 |
0.201 |
|
| 2014 |
Wood KE, Sinclair LL, Rysgaard CD, Strathmann FG, McMillin GA, Krasowski MD. Retrospective analysis of the diagnostic yield of newborn drug testing. Bmc Pregnancy and Childbirth. 14: 250. PMID 25073780 DOI: 10.1186/1471-2393-14-250 |
0.135 |
|
| 2024 |
Mastrovito R, Strathmann FG. Retraction notice to "Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing" [Clin. Biochem. 82 (2020) 85-89]. Clinical Biochemistry. 126: 110749. PMID 38503586 DOI: 10.1016/j.clinbiochem.2024.110749 |
0.12 |
|
| 2013 |
Lin CN, Strathmann FG. Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMIT. Journal of Analytical Toxicology. 37: 665-9. PMID 23843421 DOI: 10.1093/jat/bkt056 |
0.112 |
|
| 2017 |
Gehrie EA, Keiser A, Haglock-Adler CJ, Strathmann F, Booth GS. Detecting Pharmaceuticals in the Red Blood Cell Inventory of a Hospital Blood Bank. The Journal of Pediatrics. 189: 227-231.e1. PMID 28669612 DOI: 10.1016/j.jpeds.2017.06.010 |
0.103 |
|
| 2017 |
Kushnir MM, Peterson LK, Strathmann FG. Parathyroid hormone related protein concentration in human serum and CSF correlates with age. Clinical Biochemistry. PMID 29122643 DOI: 10.1016/j.clinbiochem.2017.10.018 |
0.101 |
|
| 2019 |
Kushnir MM, Michno W, Rockwood AL, Blennow K, Strathmann FG, Hanrieder J. Association of PTHrP levels in CSF with Alzheimer's disease biomarkers. Clinical Mass Spectrometry (Del Mar, Calif.). 14: 124-129. PMID 34917769 DOI: 10.1016/j.clinms.2018.10.001 |
0.098 |
|
| 2013 |
Gehrie E, Keiser A, Dawling S, Travis J, Strathmann FG, Booth GS. Primary prevention of pediatric lead exposure requires new approaches to transfusion screening. The Journal of Pediatrics. 163: 855-9. PMID 23582137 DOI: 10.1016/j.jpeds.2013.03.003 |
0.095 |
|
| 2023 |
Midthun KM, Nelson BN, Strathmann FG, Browne T, Logan BK. Analysis of umbilical cord tissue as an indicator of exposure to toxic adulterating substances. Frontiers in Pediatrics. 11: 1127020. PMID 37025298 DOI: 10.3389/fped.2023.1127020 |
0.092 |
|
| 2019 |
Pavlov IY, Parker RL, Lázár-Molnár E, Strathmann FG, Delgado JC. Inductively coupled plasma mass spectrometry assay for quantification of free infliximab in serum. Journal of Immunological Methods. PMID 31034880 DOI: 10.1016/j.jim.2019.04.008 |
0.091 |
|
| 2018 |
Hackenmueller SA, Gherasim C, Walden JQ, Law CL, Strathmann FG. Unrecognized Elevations of Toxic Elements in Urine and Blood Highlight the Potential Need for a Broader Approach to Exposure Assessment. Journal of Analytical Toxicology. PMID 30476143 DOI: 10.1093/jat/bky089 |
0.085 |
|
| 2015 |
Scholes KL, Ence AT, Strathmann FG, Genzen JR. Identification and Characterization of EDTA Test Strip Interfering Substances Using a Digital Color Detector. Clinical Laboratory. 61: 785-91. PMID 26299078 |
0.079 |
|
| 2015 |
Scholes KL, Ence AT, Strathmann FG, Genzen JR. Identification and characterization of EDTA test strip interfering substances using a digital color detector Clinical Laboratory. 61: 785-791. DOI: 10.7754/Clin.Lab.2015.150125 |
0.079 |
|
| 2014 |
Wood KE, Krasowski MD, Strathmann FG, McMillin GA. Meconium drug testing in multiple births in the USA. Journal of Analytical Toxicology. 38: 397-403. PMID 24927721 DOI: 10.1093/jat/bku061 |
0.079 |
|
| 2011 |
Strathmann FG, Ka MM, Rainey PM, Baird GS. Use of the BD vacutainer rapid serum tube reduces false-positive results for selected beckman coulter Unicel DxI immunoassays. American Journal of Clinical Pathology. 136: 325-9. PMID 21757607 DOI: 10.1309/Ajcpzofj7Kx5Qmrw |
0.076 |
|
| 2021 |
Nelson BN, Strathmann FG, Browne T, Cervantes A, Logan BK. Qualitative LC/Q-TOF Analysis of Umbilical Cord Tissue via Data-Dependent Acquisition as an Indicator of In Utero Exposure to Toxic Adulterating Substances. Journal of Analytical Toxicology. PMID 34592760 DOI: 10.1093/jat/bkab094 |
0.076 |
|
| 2015 |
Haglock-Adler CJ, Strathmann FG. Simplified sample preparation in the simultaneous measurement of whole blood antimony, bismuth, manganese, and zinc by inductively coupled plasma mass spectrometry. Clinical Biochemistry. 48: 135-9. PMID 25448028 DOI: 10.1016/j.clinbiochem.2014.11.012 |
0.076 |
|
| 2015 |
Kushnir MM, Rockwood AL, Strathmann FG, Frank EL, Straseski JA, Meikle AW. LC-MS/MS Measurement of Parathyroid Hormone-Related Peptide. Clinical Chemistry. PMID 26578690 DOI: 10.1373/Clinchem.2015.244012 |
0.073 |
|
| 2015 |
Owen WE, Thatcher ML, Crabtree KJ, Greer RW, Strathmann FG, Straseski JA, Genzen JR. Body fluid matrix evaluation on a Roche cobas 8000 system. Clinical Biochemistry. 48: 911-4. PMID 26006756 DOI: 10.1093/Ajcp/144.Suppl2.070 |
0.07 |
|
| 2018 |
Velez-Quinones MA, Xu H, Vo N, Gaitens JM, McDiarmid MA, Lewin-Smith MR, Strathmann FG. Simultaneous Determination of Uranium and Depleted Uranium Isotopic Ratio Using Inductively Coupled Mass Spectrometry. Current Protocols in Toxicology. e59. PMID 30286284 DOI: 10.1002/cptx.59 |
0.07 |
|
| 2014 |
Marin SJ, Metcalf A, Krasowski MD, Linert BS, Clark CJ, Strathmann FG, McMillin GA. Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry. Therapeutic Drug Monitoring. 36: 119-24. PMID 24061447 DOI: 10.1097/FTD.0b013e3182a0d18c |
0.063 |
|
| 2017 |
Ray JA, Kushnir MM, Meikle AW, Sindt JE, Strathmann FG. An Exploratory Study Evaluating The Impact Of Opioid And Non-Opioid Pain Medications On Serum/Plasma Free Testosterone And Free Estradiol Concentrations. Drug Testing and Analysis. PMID 28182836 DOI: 10.1002/dta.2174 |
0.062 |
|
| 2015 |
Schulte S, Rasmussen NN, McBeth JW, Richards PQ, Yochem E, Petron DJ, Strathmann FG. Utilization of the clinical laboratory for the implementation of concussion biomarkers in collegiate football and the necessity of personalized and predictive athlete specific reference intervals. The Epma Journal. 7: 1. PMID 26823691 DOI: 10.1186/s13167-016-0050-x |
0.061 |
|
| 2021 |
McDiarmid MA, Gaitens JM, Hines S, Cloeren M, Breyer R, Condon M, Oliver M, Roth T, Gucer P, Kaup B, Brown L, Brown CH, Dux M, Glick D, Lewin-Smith MR, ... Strathmann F, et al. Surveillance of Depleted Uranium-exposed Gulf War Veterans: More Evidence for Bone Effects. Health Physics. 120: 671-682. PMID 33867437 DOI: 10.1097/HP.0000000000001395 |
0.06 |
|
| 2012 |
Strathmann FG, Borlee G, Born DE, Gonzalez-Cuyar LF, Huber BR, Baird GS. Multiplex immunoassays of peptide hormones extracted from formalin-fixed, paraffin-embedded tissue accurately subclassify pituitary adenomas. Clinical Chemistry. 58: 366-74. PMID 22205691 DOI: 10.1373/Clinchem.2011.170613 |
0.06 |
|
| 2018 |
Gherasim C, Strathmann FG. 50 Retrospective Analysis of Blood Lead Levels in US Population: Assessing the Role of a National Reference Laboratory in Monitoring and Predicting Lead Contamination Events American Journal of Clinical Pathology. 149: S189-S190. DOI: 10.1093/ajcp/aqx149.419 |
0.057 |
|
| 2017 |
Straseski JA, Whale C, Wilson A, Strathmann FG. The significance of reporting to the thousandths place: Figuring out the laboratory limitations. Practical Laboratory Medicine. 7: 1-5. PMID 28856212 DOI: 10.1016/J.Plabm.2016.11.001 |
0.056 |
|
| 2018 |
McDiarmid MA, Cloeren M, Gaitens JM, Hines S, Streeten E, Breyer RJ, Brown CH, Condon M, Roth T, Oliver M, Brown L, Dux M, Lewin-Smith MR, Strathmann F, Velez-Quinones MA, et al. Surveillance results and bone effects in the Gulf War depleted uranium-exposed cohort. Journal of Toxicology and Environmental Health. Part A. 1-15. PMID 30373484 DOI: 10.1080/15287394.2018.1538914 |
0.056 |
|
| 2013 |
Straseski JA, Strathmann FG. Patient data algorithms. Clinics in Laboratory Medicine. 33: 147-60. PMID 23331735 DOI: 10.1016/J.Cll.2012.11.009 |
0.054 |
|
| 2016 |
Strathmann FG, Travis LB, Ardeshirrouhanifard S, Fossa SD, Moody S, Clarke D, Law CL. Residual Platinum Concentrations in Post-Cancer Chemotherapy and Healthy Control Populations Using an Automated, 96-Well Plate Method and Inductively Coupled Plasma Mass Spectrometry. The Journal of Applied Laboratory Medicine. 1: 143-151. PMID 33626787 DOI: 10.1373/jalm.2016.020081 |
0.052 |
|
| 2019 |
Kushnir MM, Michno W, Rockwood AL, Blennow K, Strathmann FG, Hanrieder J. Association of PTHrP levels in CSF with Alzheimer’s disease biomarkers Clinical Mass Spectrometry. 14: 124-129. DOI: 10.1016/j.clinms.2018.10.001 |
0.052 |
|
| 2019 |
Trendowski MR, El Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC, Feldman DR, ArdeshirRouhaniFard S, Hamilton R, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, ... ... Strathmann FG, et al. Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31296530 DOI: 10.1158/1078-0432.Ccr-19-0113 |
0.052 |
|
| 2016 |
Haglock-Adler CJ, McMillin GA, Strathmann FG. Development of a liquid chromatography-tandem mass spectrometry method to address the increased utilization of umbilical cord in the assessment of in utero drug exposure. Clinical Biochemistry. PMID 27131494 DOI: 10.1016/j.clinbiochem.2016.04.007 |
0.051 |
|
| 2011 |
Strathmann FG, Baird GS, Hoffman NG. Simulations of delta check rule performance to detect specimen mislabeling using historical laboratory data. Clinica Chimica Acta; International Journal of Clinical Chemistry. 412: 1973-7. PMID 21782806 DOI: 10.1016/J.Cca.2011.07.007 |
0.048 |
|
| 2015 |
Scholes KL, La'ulu SL, Ence AT, Logan HL, Parker RL, Strathmann FG, Genzen JR. Evaluation of test strips for the rapid identification of ethylenediaminetetraacetic Acid (EDTA) specimens. Laboratory Medicine. 46: 97-108. PMID 25918188 DOI: 10.1309/LMFD7CGO84FGGXST |
0.048 |
|
| 2017 |
Rasmussen NN, Barker A, Strathmann FG. Lowering the Bar for Mass Spectrometry: A Comparison between Immunoassay and Rapid Time-of-Flight for Presumptive Screening of Drugs in Urine The Journal of Applied Laboratory Medicine: An Aacc Publication. 2: 535-542. DOI: 10.1373/Jalm.2017.024166 |
0.044 |
|
| 2014 |
Schulte S, Podlog LW, Hamson-Utley JJ, Strathmann FG, Strüder HK. A systematic review of the biomarker S100B: implications for sport-related concussion management. Journal of Athletic Training. 49: 830-50. PMID 25299445 DOI: 10.4085/1062-6050-49.3.33 |
0.044 |
|
| 2020 |
Mastrovito R, Strathmann FG. Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing. Clinical Biochemistry. PMID 32142735 DOI: 10.1016/j.clinbiochem.2020.03.002 |
0.043 |
|
| 2011 |
Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clinical Chemistry. 57: 1279-85. PMID 21768219 DOI: 10.1373/clinchem.2010.161174 |
0.043 |
|
| 2012 |
Strathmann FG, Sadilkova K, Laha TJ, LeSourd SE, Bornhorst JA, Hoofnagle AN, Jack R. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 203-6. PMID 21983164 DOI: 10.1016/j.cca.2011.09.028 |
0.042 |
|
| 2015 |
McMillin GA, Marin SJ, Johnson-Davis KL, Lawlor BG, Strathmann FG. A hybrid approach to urine drug testing using high-resolution mass spectrometry and select immunoassays. American Journal of Clinical Pathology. 143: 234-40. PMID 25596249 DOI: 10.1309/Ajcpmjkbc6Vja1Sp |
0.039 |
|
| 2023 |
Cotten SW, Strathmann FG, Barrett FS, Labay L, Mullally J, Sherwood AM, Wiegand F. Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness? Clinical Chemistry. PMID 36881769 DOI: 10.1093/clinchem/hvad016 |
0.038 |
|
| 2015 |
Krasowski MD, Savage J, Ehlers A, Maakestad J, Schmidt GA, La'ulu SL, Rasmussen NN, Strathmann FG, Genzen JR. Ordering of the Serum Angiotensin-Converting Enzyme (ACE) Test in Patients Receiving ACE Inhibitor Therapy: An Avoidable but Common Error. Chest. PMID 26225637 DOI: 10.1378/chest.15-1061 |
0.038 |
|
| 2014 |
Haglock-Adler CJ, Hurley A, Strathmann FG. Use of synthetic urine as a matrix substitute for standard and quality control materials in the clinical assessment of iodine by inductively coupled plasma mass spectrometry. Clinical Biochemistry. 47: 80-2. PMID 25038425 DOI: 10.1016/j.clinbiochem.2014.07.008 |
0.037 |
|
| 2015 |
McMillin GA, Wood KE, Strathmann FG, Krasowski MD. Patterns of Drugs and Drug Metabolites Observed in Meconium; What Do They Mean? Therapeutic Drug Monitoring. PMID 25565668 DOI: 10.1097/FTD.0000000000000181 |
0.037 |
|
| 2014 |
Hackenmueller SA, Strathmann FG. Total arsenic screening prior to fractionation enhances clinical utility and test utilization in the assessment of arsenic toxicity. American Journal of Clinical Pathology. 142: 184-9. PMID 25015858 DOI: 10.1309/AJCPHUB0YEHPRAWA |
0.036 |
|
| 2012 |
Laha TJ, Strathmann FG, Wang Z, de Boer IH, Thummel KE, Hoofnagle AN. Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry. Clinical Chemistry. 58: 1711-6. PMID 22968104 DOI: 10.1373/Clinchem.2012.185827 |
0.036 |
|
| 2020 |
Strathmann FG, Lynch KL, Krotulski A, Negri P, Cichelli J, Meyer MR. Challenges of High-Resolution Mass Spectrometry For Detecting Designer Drugs. Clinical Chemistry. 66: 868-874. PMID 32628756 DOI: 10.1093/Clinchem/Hvaa118 |
0.036 |
|
| 2017 |
Powers JL, Strathmann FG, Straseski JA. Thyroglobulin Antibody Screen Prior to Mass Spectrometry Provides Measurable Cost Savings and Optimal Laboratory Utilization. American Journal of Clinical Pathology. 147: 309-314. PMID 28395053 DOI: 10.1093/Ajcp/Aqw228 |
0.036 |
|
| 2017 |
Powers JL, Rasmussen NN, Hurst D, Strathmann FG. Up in Smoke: Uncovering a Lack of Evidence for Proton Pump Inhibitors as a Source of Tetrahydrocannibol Immunoassay False Positives. Pain Medicine (Malden, Mass.). PMID 29126183 DOI: 10.1093/pm/pnx266 |
0.035 |
|
| 2012 |
Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry clinical chemistry (Clinical Chemistry (2011) 57, (1279-1285) DOI: 10.1373/clinchem.2010.161174) Clinical Chemistry. 58: 1373. DOI: 10.1373/clinchem.2012.191668 |
0.035 |
|
| 2011 |
Strathmann FG, Hoofnagle AN. Current and future applications of mass spectrometry to the clinical laboratory. American Journal of Clinical Pathology. 136: 609-16. PMID 21917684 DOI: 10.1309/AJCPW0TA8OBBNGCK |
0.034 |
|
| 2017 |
Haglock-Adler CJ, Gruzdys V, Strathmann FG. Establishment and verification of chromium and cobalt concentrations in joint fluids from a reference population Clinical Mass Spectrometry. 6: 32-35. DOI: 10.1016/j.clinms.2017.11.003 |
0.032 |
|
| 2016 |
Strathmann FG, Travis LB, Ardeshirrouhanifard S, Fossa SD, Moody S, Clarke D, Law CL. Residual Platinum Concentrations in Post-Cancer Chemotherapy and Healthy Control Populations Using an Automated, 96-Well Plate Method and Inductively Coupled Plasma Mass Spectrometry The Journal of Applied Laboratory Medicine: An Aacc Publication. 1: 143-151. DOI: 10.1373/jalm.2016.020081 |
0.031 |
|
| 2018 |
Rasmussen NN, Barker A, Strathmann FG. Lowering the Bar for Mass Spectrometry: A Comparison between Immunoassay and Rapid Time-of-Flight for Presumptive Screening of Drugs in Urine. The Journal of Applied Laboratory Medicine. 2: 535-542. PMID 33636881 DOI: 10.1373/jalm.2017.024166 |
0.031 |
|
| 2015 |
Owen WE, Thatcher ML, Crabtree KJ, Greer RW, Strathmann FG, Straseski JA, Genzen JR. Body fluid matrix evaluation on a Roche cobas 8000 system Clinical Biochemistry. DOI: 10.1016/j.clinbiochem.2015.05.012 |
0.03 |
|
| 2014 |
Strathmann FG, Schulte S, Goerl K, Petron DJ. Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives. Clinical Biochemistry. 47: 876-88. PMID 24486649 DOI: 10.1016/j.clinbiochem.2014.01.028 |
0.029 |
|
| 2014 |
Ward MB, Hackenmueller SA, Strathmann FG. Pathology consultation on urine compliance testing and drug abuse screening. American Journal of Clinical Pathology. 142: 586-93. PMID 25319972 DOI: 10.1309/AJCPZ0DS4QLYNCQG |
0.029 |
|
| 2023 |
McDiarmid MA, Hines S, Cloeren M, Gucer P, Condon M, Oliver M, Roth T, Lewin-Smith MR, Strathmann F, Velez-Quinones MA, Gaitens JM. The Department of Veterans' Affairs Depleted Uranium Cohort in the Time of COVID-19: Translating a Traditional Surveillance Protocol to a Telehealth Platform. Journal of Occupational and Environmental Medicine. PMID 37167933 DOI: 10.1097/JOM.0000000000002875 |
0.026 |
|
| 2016 |
Doyle K, Strathmann FG. Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing Strategy. Pain Medicine (Malden, Mass.). PMID 27425189 DOI: 10.1093/pm/pnw165 |
0.025 |
|
| 2020 |
Gaitens JM, Brown CH, Strathmann FG, Xu H, Lewin-Smith MR, Velez-Quinones MA, McDiarmid MA. The Utility of Spot vs 24-Hour Urine Samples for Metal Determination in Veterans With Retained Fragments. American Journal of Clinical Pathology. PMID 33083816 DOI: 10.1093/ajcp/aqaa144 |
0.024 |
|
| 2017 |
Clark ZD, Cutler JM, Pavlov IY, Strathmann FG, Frank EL. Simple dilute-and-shoot method for urinary vanillylmandelic acid and homovanillic acid by liquid chromatography tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 28263737 DOI: 10.1016/j.cca.2017.03.004 |
0.023 |
|
| 2015 |
McMillin GA, Wood KE, Strathmann FG, Krasowski MD. Patterns of drugs and drug metabolites observed in meconium: What do they mean? Therapeutic Drug Monitoring. 37: 568-580. |
0.017 |
|
| 2017 |
Taylor LL, Flint NA, Ma V, Hill BM, Clark CJ, Strathmann FG. Internal Hydrolysis Indicator for Sample Specific Monitoring of β-Glucuronidase Activity. Journal of Analytical Toxicology. 1-5. PMID 28334921 DOI: 10.1093/jat/bkx027 |
0.016 |
|
| 2020 |
Murphy RT, Blum LM, Strathmann FG. Rapid and efficient semiquantitative screening for elemental contamination of sample collection containers. Clinical Biochemistry. PMID 32145246 DOI: 10.1016/j.clinbiochem.2020.03.003 |
0.013 |
|
| 2017 |
Doyle K, Strathmann FG. Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing Strategy. Pain Medicine (Malden, Mass.). 18: 307-315. PMID 28204701 DOI: 10.1093/pm/pnw165 |
0.013 |
|
| 2018 |
Gruzdys V, Law C, Strathmann FG. 58 Was That the Right Decision? A Post-Mortem Analysis of a Multi-Year Quality Improvement Process American Journal of Clinical Pathology. 149: S194-S194. DOI: 10.1093/ajcp/aqx149.427 |
0.01 |
|
| 2015 |
Strathmann FG. N-of-1 Clinical Trials: Removing the Hay to Find the Needle. Clinical Chemistry. 61: 1550-1. PMID 26949766 |
0.01 |
|
| 2015 |
Strathmann FG. N-of-1 clinical trials: Removing the hay to find the needle Clinical Chemistry. 61: 1550-1551. DOI: 10.1373/clinchem.2015.245928 |
0.01 |
|
| Hide low-probability matches. |